CHRFAM7A expression in mice increases resiliency after injury

被引：0
|
作者：
Todd W. Costantini
Raul Coimbra
Jessica L. Weaver
Brian P. Eliceiri
机构：
[1] UC San Diego School of Medicine,Division of Trauma, Surgical Critical Care, Burns and Acute Care Surgery, Department of Surgery
[2] Riverside University Health System,Comparative Effectiveness and Clinical Outcomes Research Center
[3] Loma Linda University School of Medicine,undefined
来源：
Inflammation Research | 2022年 / 71卷
关键词：
sepsis; burn; lung permeability; survival; human gene;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 11
页数：2
相关论文
共 50 条
  • [41] THE DUPLICATED α7 NICOTINIC RECEPTOR GENE, CHRFAM7A, IS A DOMINANT NEGATIVE REGULATOR OF THE FULL-LENGTH GENE, CHRNA7
    Leonard, Sherry
    Sinkus, M.
    Bertrand, D.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 193 - 193
  • [42] CHRNA7 and CHRFAM7A mRNAs: Co-Localized and Their Expression Levels Altered in the Postmortem Dorsolateral Prefrontal Cortex in Major Psychiatric Disorders
    Kunii, Yasuto
    Zhang, Wenyu
    Xu, Qing
    Hyde, Thomas M.
    McFadden, Whitney
    Shin, Joo Heon
    Deep-Soboslay, Amy
    Ye, Tianzhang
    Li, Chao
    Kleinman, Joel E.
    Wang, Kuan Hong
    Lipska, Barbara K.
    AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (11): : 1122 - 1130
  • [43] Expression of the α7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS
    Benfante, Roberta
    Antonini, Ruth Adele
    De Pizzol, Maria
    Gotti, Cecilia
    Clementi, Francesco
    Locati, Massimo
    Fornasari, Diego
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 230 (1-2) : 74 - 84
  • [44] The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function
    Araud, Tanguy
    Graw, Sharon
    Berger, Ralph
    Lee, Michael
    Neveu, Estele
    Bertrand, Daniel
    Leonard, Sherry
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (08) : 904 - 914
  • [45] Expression of CHRFAM7A and CHRNA7 in neuronal cells and postmortem brain of HIV-infected patients: considerations for HIV-associated neurocognitive disorder
    Félix M. Ramos
    Manuel Delgado-Vélez
    Ángel L. Ortiz
    Carlos A. Báez-Pagán
    Orestes Quesada
    José A. Lasalde-Dominicci
    Journal of NeuroVirology, 2016, 22 : 327 - 335
  • [46] CHRFAM7A IS A HUMAN-SPECIFIC INHIBITOR OF THE CHOLINERGIC ANTI-INFLAMMATORY RESPONSE IN DENDRITIC CELLS
    Aubin, Myriam
    Cohen, Olga
    Eliceiri, Brian P.
    Baird, Andrew
    Costantini, Todd
    SHOCK, 2020, 53 : 92 - 92
  • [47] CHRFAM7A, a human-specific and partially duplicated α7-nicotinic acetylcholine receptor gene with the potential to specify a human-specific inflammatory response to injury
    Costantini, Todd W.
    Dang, Xitong
    Coimbra, Raul
    Eliceiri, Brian P.
    Baird, Andrew
    JOURNAL OF LEUKOCYTE BIOLOGY, 2015, 97 (02) : 247 - 257
  • [48] Structure, Dynamics, and Ligand Recognition of Human-Specific CHRFAM7A (Dupα7) Nicotinic Receptor Linked to Neuropsychiatric Disorders
    Liu, Danlin
    de Souza, Joao V.
    Ahmad, Ayaz
    Bronowska, Agnieszka K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [49] Association study of CHRFAM7A copy number and 2bp deletion polymorphisms with schizophrenia and bipolar affective disorder
    Flomen, Rachel H.
    Collier, David A.
    Osborne, Sarah
    Munro, Janet
    Breen, Gerome
    St Clair, David
    Makoff, Andrew J.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (06) : 571 - 575
  • [50] CHRFAM7A: A human specific fusion gene, accounts for the translational gap for cholinergic strategies in Alzheimer's disease
    Szigeti, Kinga
    Ihnatovych, Ivanna
    Birkaya, Barbara
    Chen, Ziqiang
    Ouf, Aya
    Indurthi, Dinesh C.
    Bard, Jonathan E.
    Kann, Julien
    Adams, Alexandrea
    Chaves, Lee
    Sule, Norbert
    Reisch, Joan S.
    Pavlik, Valory
    Benedict, Ralph H. B.
    Auerbach, Anthony
    Wilding, Gregory
    EBIOMEDICINE, 2020, 59
12345